The Alliance recognizes the efforts of other healthcare organizations engaged in the evidence-driven advancement of digital therapeutics to improve patient outcomes. DTA is committed to supporting the ongoing work of organizations aligned with the Alliance’s mission.
DTA members include digital therapeutic companies, healthcare providers, payers, academic institutions, patient groups, investors, technology and data organizations, pharmaceutical manufacturers, in addition to other organizations actively engaged in the digital therapeutics industry.
Digital therapeutics are clinically-validated solutions that may be used as standalone direct treatments or in association with other treatments to improve the overall quality, cohesion, outcomes, and value of healthcare delivery. Digital therapeutics demonstrate safety and efficacy in randomized control trials, receive regulatory clearance when used as a medical device, integrate into clinical practice, and are tailored to patients’ clinical needs, goals, and lifestyles. These solutions consist of patient-facing treatments, clinical assessment and outcomes tracking tools, clinician monitoring dashboards, and HIPAA-compliant data storage.